LSRCX
Price
$1.08
Change
-$0.01 (-0.92%)
Updated
Sep 1 closing price
Net Assets
400.37M
SSGSX
Price
$52.21
Change
-$0.61 (-1.15%)
Updated
Sep 1 closing price
Net Assets
4.22B
Interact to see
Advertisement

LSRCX vs SSGSX

LSRCX vs SSGSX Comparison Chart in %
View a ticker or compare two or three
VS
LSRCX vs. SSGSX commentary
Sep 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSRCX is a Hold and SSGSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SSGSX has more cash in the bank: 4.22B vs. LSRCX (400M). LSRCX pays higher dividends than SSGSX: LSRCX (3.01) vs SSGSX (0.52). LSRCX was incepted earlier than SSGSX: LSRCX (29 years) vs SSGSX (27 years). LSRCX (1.96) is less costly to investors than SSGSX (1.23). LSRCX is a more actively managed with annual turnover of: 69.00 vs. SSGSX (50.00). LSRCX has a lower initial minimum investment than SSGSX: LSRCX (1000) vs SSGSX (2500). SSGSX annual gain was more profitable for investors over the last year : 13.12 vs. LSRCX (-41.08). SSGSX return over 5 years is better than : -3.94 vs. LSRCX (-82.00).
LSRCXSSGSXLSRCX / SSGSX
Total Expense Ratio1.961.23159%
Annual Report Gross Expense Ratio1.961.23159%
Fund Existence29 years27 years-
Gain YTD17.20418.19295%
Front LoadN/A6%-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets400M4.22B9%
Annual Yield % from dividends3.010.52578%
Returns for 1 year-41.0813.12-313%
Returns for 3 years-62.6410.23-612%
Returns for 5 years-82.00-3.942,084%
Returns for 10 years-92.7533.59-276%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ICCC9.920.13
+1.33%
ImmuCell Corp
CEPF10.440.08
+0.77%
Cantor Equity Partners IV Inc.
CAPS0.19N/A
-0.05%
Capstone Holding Corp
ASND260.25-2.79
-1.06%
Ascendis Pharma A/S
SHAK67.62-1.27
-1.84%
Shake Shack